Home » Stocks » OpGen, Inc.

OpGen, Inc. (OPGN)

Stock Price: $2.39 USD 0.02 (1.01%)
Updated Oct 22, 2020 11:15 AM EDT - Market open

Stock Price Chart

Key Info

Market Cap 47.40M
Revenue (ttm) 3.27M
Net Income (ttm) -17.43M
Shares Out 19.80M
EPS (ttm) -2.49
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 22, 2020
Last Price $2.39
Previous Close $2.37
Change ($) 0.02
Change (%) 1.01%
Day's Open 2.38
Day's Range 2.35 - 2.44
Day's Volume 190,599
52-Week Range 0.92 - 7.05

More Stats

Market Cap 47.40M
Enterprise Value 55.31M
Earnings Date (est) Nov 11, 2020
Ex-Dividend Date n/a
Shares Outstanding 19.80M
Float 19.76M
EPS (basic) 0.65
EPS (diluted) -2.49
FCF / Share -0.97
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 2.24M
Short Ratio 2.22
Short % of Float 11.34%
Beta -0.56
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 14.48
PB Ratio 2.53
Revenue 3.27M
Operating Income -16.44M
Net Income -17.43M
Free Cash Flow -14.92M
Net Cash -7.91M
Net Cash / Share -0.40
Gross Margin -99.39%
Operating Margin -502.13%
Profit Margin -532.20%
FCF Margin -455.75%
ROA -32.69%
ROE -169.54%
ROIC -198.20%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (2)

Buy 2
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(108.86% upside)
Current: $2.39
Target: 5.00
*Average 12-month price target from 2 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth18.75%-8.24%-20.24%27.49%-23.47%71.18%-
Gross Profit1.871.101.081.741.613.170.59
Operating Income-12.27-13.18-15.27-19.01-15.06-5.56-10.33
Net Income-12.45-13.37-15.42-19.17-17.35-5.67-10.13
Shares Outstanding1.620.300.080.040.02--
Earnings Per Share-7.70-44.49-196.00-551.80-1,100.00-8,125.00-448,045.00
Operating Cash Flow-11.51-11.07-14.30-17.25-14.28-5.39-7.49
Capital Expenditures--0.14-0.28-0.12-0.19-0.04-0.11
Free Cash Flow-11.51-11.21-14.58-17.37-14.46-5.43-7.60
Cash & Equivalents5.234.571.854.127.810.751.40
Total Debt3.161.901.301.351.573.240.35
Net Cash / Debt2.072.680.552.766.24-2.491.05
Book Value4.293.311.403.177.49-8.07-1.83
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name OpGen, Inc.
Country United States
Employees 38
CEO Oliver Schacht

Stock Information

Ticker Symbol OPGN
Stock Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Unique Identifier NASDAQ: OPGN
IPO Date May 5, 2015


OpGen, a precision medicine company, engages in developing molecular information products and services in the United States and internationally. The company utilizes molecular diagnostics and informatics to help combat infectious diseases. It also helps clinicians with information about life threatening infections, enhance patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms. The company's products include Acuitas AMR Gene Panel, a vitro diagnostic test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance in urine specimens or bacterial colonies isolated from urine and other body sites; and QuickFISH and PNA FISH products, which are FDA-cleared and CE-marked diagnostic test designed to detect pathogens in positive blood cultures. In addition, it offers Acuitas Lighthouse informatics systems, a cloud-based HIPAA compliant informatics offerings, which combine clinical lab test results with patient and hospital information, and provide analytics and insights to enable manage MDROs in the hospital and patient care environment. OpGen, Inc. has a strategic collaboration with the New York State Department of Health to develop a solution to detect, track, and manage antimicrobial-resistant infections at healthcare institutions. The company was incorporated in 2001 and is headquartered in Gaithersburg, Maryland.